Metabolic Liver Research Program, University Medical Center Mainz
Bestätigte
Multistakeholder Approach to Innovations in NAFLD Care
Discover the importance of a multistakeholder approach in NAFLD care, addressing the challenges of comorbidities, patient identification, and innovative strategies to improve treatment outcomes and healthcare coordination.
Read MoreMultistakeholder Approach to Innovations in NAFLD CareMultistakeholder Approach to Innovations in NAFLD Care Slides
Explore with the slides the significance of a multistakeholder approach in NAFLD care as it tackles the complexities of comorbidities, patient detection, and groundbreaking tactics to enhance treatment results and healthcare collaboration.
Read MoreMultistakeholder Approach to Innovations in NAFLD Care SlidesNon-Invasive Assessment of cACLD and Portal Hypertension
Dr. Jörn Schattenberg (Germany) analyses the latest on the assessment in cirrhosis along with his own case study.
Read MoreNon-Invasive Assessment of cACLD and Portal HypertensionNASH and Quality of Life
Prof Schattenberg, Germany, reviews how NASH impacts quality of life. He presents the mechanisms underlying metabolic comorbidities in NASH and discusses the relevant NASH phenotypes.
Read MoreNASH and Quality of Life